Skip to main content

Advertisement

SpringerLink
Log in

Long-term follow-up in a patient with the dermato-neuro syndrome treated with high-dose melphalan, thalidomide, and intravenous immunoglobulins for more than 7 years

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Rongioletti F, Rebora A (2001) Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedema. J Am Acad Dermatol 44:273–281

    Article  PubMed  CAS  Google Scholar 

  2. River Y, Levy I, Gilead L et al (1996) Fever, convulsions and coma in scleromyxedema: a “dermato-neuro syndrome”. Neurology 46:1778–1779

    Article  PubMed  CAS  Google Scholar 

  3. Fleming KE, Virmani D, Sutton E et al (2012) Scleromyxedema and the dermato-neuro syndrome: case report and review of the literature. J Cutan Pathol 39:508–517

    Article  PubMed  Google Scholar 

  4. Johkura K, Susuki K, Hasegawa O et al (1999) Encephalopathy in scleromyxedema. Neurology 53:1138–1140

    Article  PubMed  CAS  Google Scholar 

  5. Webster GF, Matsuoka LY, Burchmore D (1993) The association of potentially lethal neurologic syndromes with scleromyxedema (papular mucinosis). J Am Acad Dermatol 28:105–108

    Article  PubMed  CAS  Google Scholar 

  6. Berger JR, Dobbs MR, Terhune MH et al (2001) The neurologic complications of scleromyxedema. Medicine 80:313–319

    Article  PubMed  CAS  Google Scholar 

  7. Lister RK, Jolles S, Whittaker S et al (2000) Scleromyxedema: response to high-dose intravenous immunoglobulin (hdIVIg). J Am Acad Dermatol 43:403–408

    Article  PubMed  CAS  Google Scholar 

  8. Donato ML, Feasel AM, Weber DM, Prieto VG, Giralt S, Champlin RE et al (2006) Scleromyxedema: role of high-dose melphalan with autologous stem cell transplantation. Blood 107:463–466

    Article  PubMed  CAS  PubMed Central  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Hematology, University Hospitals Leuven, Leuven, Belgium

    T. Devos & M. Delforge

  2. Department of Anesthesiology, University Hospitals Leuven, Leuven, Belgium

    S. Thiessen

  3. Department of Gastro-Enterology, Imelda Ziekenhuis, Bonheiden, Belgium

    P. J. Cuyle

  4. Department of Internal Medicine, University Hospitals Leuven, Leuven, Belgium

    W. Meersseman

Authors
  1. T. Devos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Thiessen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. J. Cuyle
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. W. Meersseman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Delforge
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T. Devos.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Devos, T., Thiessen, S., Cuyle, P.J. et al. Long-term follow-up in a patient with the dermato-neuro syndrome treated with high-dose melphalan, thalidomide, and intravenous immunoglobulins for more than 7 years. Ann Hematol 93, 1927–1928 (2014). https://doi.org/10.1007/s00277-014-2065-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-014-2065-5

Keywords

Search

Navigation